Alzheimer's clinical trials in need of more Black participants

Studies show Black Americans are impacted twice as much as white Americans when it comes to Alzheimer's disease. The number of Black Americans involved in research and clinical trials is low. Wake Forest School of Medicine is on a mission to diversify research and close the gap.

Dr. Goldie Byrd is the director of the Maya Angelou Center for Health Equity at Wake Forest School of Medicine. She has spent much of her career researching the genetics of Alzheimer's in African Americans with a particular emphasis on diversifying research studies in clinical trials.

Read more here: https://www.wfmynews2.com/article/news/health/researchers-looking-for-13000-black-and-hispanic-people-for-alzheimers-study/83-eac9bfed-2bd6-4b31-a71c-9f9e164d4f03

SUBSCRIBE | https://bit.ly/2vsX74I

Follow us:
Facebook | https://bit.ly/3326pAY
Twitter | https://bit.ly/2vIPZkT
Instagram | https://bit.ly/39Ghs5a

Download the WFMY News 2 app:
►Text the word APP to 336-379-5775
►For iPhone | https://apple.co/3aaH6iM
►For Android | https://bit.ly/3aea9Sv